Misread UTI Sparks Rare T-Cell Lymphoma Battle, Ends in Remission
Emma Operacz, a college student, was treated for a presumed UTI until a biopsy revealed stage-four T-cell lymphoma; after conventional chemotherapy failed, doctors at Cleveland Clinic used a targeted therapy (Alectinib) that led to remission, followed by a bone marrow transplant. She recovered, returned to school, and plans to pursue graduate study, saying she was “mad at the world” during her darkest days.